A comparison of catheter lock solutions and associated complications in pediatric intestinal failure patients

比较导管封管液及其在儿童肠衰竭患者中的相关并发症

阅读:1

Abstract

BACKGROUND: Children with intestinal failure (IF) receiving parenteral nutrition (PN) are at risk for central venous catheter (CVC) associated complications including infection, occlusion, and breakage. A variety of catheter locks have been used to preserve patency and prevent infection when catheters are not in use. Taurolidine (T) and Ethylenediaminetetraacetic acid (EDTA) locks have antimicrobial and anticoagulant properties; however, superiority of one is unclear. MATERIAL AND METHODS: A multicenter, retrospective review of children with IF on PN and receiving care from an Intestinal Rehabilitation team (2017-2022) was performed. Children using T or EDTA locks were included, and those with incomplete records were excluded. Rates of central line associated bloodstream infections (CLABSIs), occlusions, and breakages were compared and reported as mean events per 1000 catheter days (CDs) with standard errors (SE). Analysis was performed using the Mann-Whitney test. RESULTS: 48 children (4 months-16 years) were included for a total of 112 catheters, mostly single lumen, peripherally inserted central catheters (76 %) or tunneled CVCs (21 %). T and EDTA locks accounted for 22,530 CDs and 7913 CDs respectively. Rates of CLABSIs did not differ between groups (T 1.5/1000 CDs, SE=0.79, and EDTA 0.4/1000 CDs, SE=0.41, p = 0.17). CVC occlusions requiring catheter replacement were similar (2.3 vs. 1.3 per 1000 CDs, p = 1.00) as were fractures requiring replacement (4.0 vs. 2.1 per 1000 CDs, p = 0.73). CONCLUSION: Taurolidine and EDTA locks are similarly effective in preventing infections and equally likely to be associated with occlusion or breakage. Both are suitable for children with IF on long-term PN.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。